Literature DB >> 15349806

Nutrition and alcoholic liver disease.

Charles H Halsted1.   

Abstract

Malnutrition is a common finding in chronic alcoholics, and protein calorie malnutrition (PCM) is universal and predictive of survival in patients with established alcoholic liver disease (ALD). These patients also demonstrate frequent deficiencies of folate, thiamine, pyridoxine, and vitamin A, which enhance the likelihood of anemia, altered cognitive states, and night blindness. The etiologies of malnutrition in ALD patients are multiple and interactive and include anorexia with inadequate dietary intake, abnormal digestion of macronutrients and absorption of several micronutrients, increased skeletal and visceral protein catabolism, and abnormal interactions of ethanol and lipid metabolism. Numerous, and mostly inadequately controlled, studies have evaluated the potential efficacies of oral, enteral, and parenteral nutrition approaches to treatment of ALD, with mixed results on liver function, clinical improvements, and short- or long-term survival. Targeted metabolic treatments include supplementation with S-adenosylmethionine (SAM) or phosphatidylcholine derivatives, each with promising experimental bases but inconclusive clinical trials.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15349806     DOI: 10.1055/s-2004-832941

Source DB:  PubMed          Journal:  Semin Liver Dis        ISSN: 0272-8087            Impact factor:   6.115


  29 in total

Review 1.  Specific topics and complications of parenteral nutrition.

Authors:  Eduardo E Montalvo-Jave; José L Zarraga; Michael G Sarr
Journal:  Langenbecks Arch Surg       Date:  2007-01-13       Impact factor: 3.445

2.  Multiple vitamin deficiencies in a patient with a history of chronic alcohol excess and self-neglect in the UK.

Authors:  Jon Mark Dickson; Greg Naylor; Graham Colver; Hilary J Powers; Paul Masters
Journal:  BMJ Case Rep       Date:  2014-09-22

3.  Treatment of alcoholic liver disease.

Authors:  Thomas H Frazier; Abigail M Stocker; Nicole A Kershner; Luis S Marsano; Craig J McClain
Journal:  Therap Adv Gastroenterol       Date:  2011-01       Impact factor: 4.409

Review 4.  Vitamin-dependent methionine metabolism and alcoholic liver disease.

Authors:  Charles H Halsted; Valentina Medici
Journal:  Adv Nutr       Date:  2011-09-06       Impact factor: 8.701

Review 5.  Current concepts and controversies in the treatment of alcoholic hepatitis.

Authors:  Catherine Rongey; Neil Kaplowitz
Journal:  World J Gastroenterol       Date:  2006-11-21       Impact factor: 5.742

6.  Alcoholic liver disease.

Authors:  Radan Bruha; Karel Dvorak; Jaromir Petrtyl
Journal:  World J Hepatol       Date:  2012-03-27

7.  Epigenetic regulation of hepatic endoplasmic reticulum stress pathways in the ethanol-fed cystathionine beta synthase-deficient mouse.

Authors:  Farah Esfandiari; Valentina Medici; Donna H Wong; Soumia Jose; Maryam Dolatshahi; Eoin Quinlivan; Sanjana Dayal; Steven R Lentz; Hidekazu Tsukamoto; Yue Hua Zhang; Samuel W French; Charles H Halsted
Journal:  Hepatology       Date:  2010-03       Impact factor: 17.425

8.  Maternal nutritional status as a contributing factor for the risk of fetal alcohol spectrum disorders.

Authors:  Philip A May; Kari J Hamrick; Karen D Corbin; Julie M Hasken; Anna-Susan Marais; Jason Blankenship; H Eugene Hoyme; J Phillip Gossage
Journal:  Reprod Toxicol       Date:  2015-12-03       Impact factor: 3.143

9.  Ethanol inhibits functional activity of the human intestinal dipeptide transporter hPepT1 expressed in Xenopus oocytes.

Authors:  Kaixun Li; Liya Xu; Ashutosh A Kulkarni; Daya I Perkins; Ian S Haworth; Daryl L Davies
Journal:  Alcohol Clin Exp Res       Date:  2008-03-11       Impact factor: 3.455

Review 10.  Nutrition and Alcoholic Liver Disease: Effects of Alcoholism on Nutrition, Effects of Nutrition on Alcoholic Liver Disease, and Nutritional Therapies for Alcoholic Liver Disease.

Authors:  Srinivasan Dasarathy
Journal:  Clin Liver Dis       Date:  2016-04-23       Impact factor: 6.126

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.